BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Deals

  Medtronic to Acquire Bay Area Lazarus Effect for $100M

  September 28, 2015

   · 

  4 min read
• Policy

  Sun Pharma Group Stocks Dip on U.S. FDA Denial for its Epilepsy Drug

  September 28, 2015

   · 

  1 min read
• FDA

  Novo Nordisk A/S Finally Bags Diabetes Drug Tresiba U.S. Approval

  September 28, 2015

   · 

  6 min read
• Drug Development

  DelMar Pharmaceuticals To Present An Interactive Live Webcast At VirtualInvestorConferences.com On October 1, 2015

  September 28, 2015

   · 

  6 min read
• Drug Development

  Aduro Biotech Announces Phase 1b Mesothelioma Trial Featured In Spotlight Poster At ESMO/ECC

  September 28, 2015

   · 

  6 min read
• Drug Development

  RXi Pharmaceuticals Granted Patent In China For Lead Clinical Candidate RXI-109

  September 28, 2015

   · 

  5 min read
• Drug Development

  Syndax And Merck & Co. Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And KEYTRUDA

  September 28, 2015

   · 

  13 min read
• Drug Development

  Cellectar Biosciences Announces Pricing Of $3.3 Million Financing

  September 28, 2015

   · 

  4 min read
• Drug Development

  Merck & Co. Release: New Findings Show Anti-Tumor Activity Of KEYTRUDA(Pembrolizumab) In Patients With Advanced Nasopharyngeal Carcinoma

  September 28, 2015

   · 

  14 min read
• Drug Development

  Catalyst Biosciences Names Andrew Hetherington As Vice President Of Manufacturing Operations

  September 28, 2015

   · 

  4 min read